tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

KTTA Stock Latest News

Pasithea Therapeutics presents updated interim data from Phase 1 PAS-004 study
The FlyPasithea Therapeutics presents updated interim data from Phase 1 PAS-004 study
6d ago
KTTA
Pasithea Therapeutics announces preclinical data on PAS-004
PremiumThe Fly
Pasithea Therapeutics announces preclinical data on PAS-004
19d ago
KTTA
Pasithea Therapeutics announces initiation of Phase 1/1b study of PAS-004
PremiumThe Fly
Pasithea Therapeutics announces initiation of Phase 1/1b study of PAS-004
25d ago
KTTA
3 Penny Stocks to Watch Now, 5/8/25
PremiumMarket News
3 Penny Stocks to Watch Now, 5/8/25
1M ago
FOXO
KTTA
Pasithea Therapeutics Raises $6.3 Million in Stock Offering
PremiumCompany Announcements
Pasithea Therapeutics Raises $6.3 Million in Stock Offering
1M ago
8K
KTTA
Pasithea Therapeutics 3.57M share Secondary priced at $1.40
PremiumThe FlyPasithea Therapeutics 3.57M share Secondary priced at $1.40
1M ago
KTTA
Pasithea Therapeutics announces interim data from Phase 1 trial of PAS-004
Premium
The Fly
Pasithea Therapeutics announces interim data from Phase 1 trial of PAS-004
1M ago
KTTA
Pasithea Therapeutics files to sell 3.25M shares of common stock, warrants
Premium
The Fly
Pasithea Therapeutics files to sell 3.25M shares of common stock, warrants
1M ago
KTTA
Pasithea completes enrollment in cohort 6 of Phase 1 trial of PAS-004
PremiumThe Fly
Pasithea completes enrollment in cohort 6 of Phase 1 trial of PAS-004
1M ago
KTTA
Pasithea Therapeutics to present updated data from Phase 1 trial of PAS-004
PremiumThe Fly
Pasithea Therapeutics to present updated data from Phase 1 trial of PAS-004
1M ago
KTTA
Morning Movers: Capri Holdings jumps following sale of Versace to Prada
PremiumThe Fly
Morning Movers: Capri Holdings jumps following sale of Versace to Prada
2M ago
X
ASX
Pasithea says SRC recommends Phase 1 PAS-004 trial escalate to next dose level
PremiumThe Fly
Pasithea says SRC recommends Phase 1 PAS-004 trial escalate to next dose level
2M ago
KTTA
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
ACET
ACHL
Pasithea announces Safety Review Committee recommendation
Premium
The Fly
Pasithea announces Safety Review Committee recommendation
4M ago
KTTA
Pasithea Therapeutics opens three clinical trial sites in Eastern Europe
Premium
The Fly
Pasithea Therapeutics opens three clinical trial sites in Eastern Europe
5M ago
KTTA
Pasithea Therapeutics announces SRC recommended proceeding to cohort 4
PremiumThe Fly
Pasithea Therapeutics announces SRC recommended proceeding to cohort 4
7M ago
KTTA
Pasithea Therapeutics files to sell 3.74M shares of common stock for holders
PremiumThe Fly
Pasithea Therapeutics files to sell 3.74M shares of common stock for holders
8M ago
KTTA
Pasithea Therapeutics prices $5M at-the-market private placement at $4.10/share
PremiumThe Fly
Pasithea Therapeutics prices $5M at-the-market private placement at $4.10/share
8M ago
KTTA
Morning Movers: Micron and Accenture rise following quarterly results
PremiumThe Fly
Morning Movers: Micron and Accenture rise following quarterly results
8M ago
MU
ACN
Pasithea Therapeutics announces initial data from Phase 1 trial of PAS-004
PremiumThe FlyPasithea Therapeutics announces initial data from Phase 1 trial of PAS-004
8M ago
KTTA
Pasithea Therapeutics completes PAS-004 chronic toxicity studies
Premium
The Fly
Pasithea Therapeutics completes PAS-004 chronic toxicity studies
9M ago
KTTA
Pasithea Therapeutics appoints Rebecca Brown to Scientific Advisory Board
Premium
The Fly
Pasithea Therapeutics appoints Rebecca Brown to Scientific Advisory Board
9M ago
KTTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >